Clinical Trial Update: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 update reporting safety, pharmacokinetics, and preliminary efficacy data for AI-061 in advanced solid tumors across multiple indications. The study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Head and Neck Squamous Cell Carcinoma
• High-grade Serous Ovarian Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Peritoneal Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• AI-061

Snippet

Sponsor: OncoC4, Inc. | Conditions: Melanoma, Non Small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING